5Koutush A and Chapman MJ. Functionally defective HDL: a new therapeutic target at the crossroads of dyslipidemia, inflammation and atherosclerosis [ J ]. Pharmacology Reviews, 2006, 3 : 342- 374.
7Tanaka A. Role and metabolism of high density lipoprotein subfractions - analysis of serem HDL2-cholesterol and HDL3-cholesterol in patients with various diseases by high performance liquid chromatography[J]. Bull Tokyo Med Dent Univ, 1982, 29(4) : 131-137.
8YU SC, Yarnell JWG, Sweetnam P, et al. High density lipoprotein subfractions and the risk of coronary heart disease :9-years followup in the Caerphily study [ J ]. Atherosclerosis, 2003, 166 (2) :331-339.
9Mckenney JM, Jones PH, Bays HE, et al. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a stain alone [ J ]. Atheroslerosis, 2007, 192(2) :432-437.